XTX Topco Ltd

Position in FULC — Fulcrum Therapeutics, Inc.

CIK 1828301 LONDON, X0

Position in FULC

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$765,844

+$216,649 QoQ

Shares Held

209,247

+192.2% QoQ

Ownership

0.274%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#45

of 154 holders

Holding Since

Jun 2022

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

XTX Topco Ltd holds $413,187,957 across 381 Biotechnology names. FULC ranks #142 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	30,522	$19,031,687
2	ASND	Ascendis Pharma A/S	43,289	$11,546,042
3	BBIO	BridgeBio Pharma, Inc.	116,611	$8,685,187
4	MRNA	Moderna, Inc.	123,281	$8,633,368
5	JAZZ	Jazz Pharmaceuticals plc	30,496	$7,348,621
6	KYMR	Kymera Therapeutics, Inc.	61,501	$7,052,319
7	CYTK	Cytokinetics Inc	80,743	$6,878,496
8	PTCT	Ptc Therapeutics, Inc.	81,923	$6,682,459

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$765,844	209,247	+192.2%	Shares	Defined	2026-08-14
2026-03-31	$549,195	71,603	+38.2%	Shares	Defined	2026-05-15
2025-12-31	$585,880	51,802	+3.9%	Shares	Defined	2026-02-17
2025-03-31	$143,648	49,878	+279.2%	Shares	Defined	2025-05-08
2024-03-31	$124,173	13,154	-66.2%	Shares	Defined	2024-05-13
2023-09-30	$172,795	38,918	-53.2%	Shares	Defined	2023-11-13
2023-06-30	$274,447	83,166	-32.8%	Shares	Defined	2023-08-14
2023-03-31	$352,738	123,768	+254.8%	Shares	Defined	2023-05-12
2022-12-31	$253,940	34,882	+25.5%	Shares	Defined	2023-02-14
2022-06-30	$136,215	27,799	—	Shares	Defined	2022-08-15
No filing history on record for this holder in this stock.